These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16079463)

  • 1. Effects of 5-HT1A-receptor agonist, 8-OH-DPAT, and GABAB-receptor agonist, baclofen, on lordosis in female rats with lesions in either the dorsal raphe nucleus or septum.
    Kishitake M; Yamanouchi K
    J Pharmacol Sci; 2005 Aug; 98(4):419-24. PubMed ID: 16079463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of baclofen on lordosis in female and male rats with dorsal raphe nucleus lesion or septal cut.
    Kakeyama M; Yamanouchi K
    Neuroendocrinology; 1996 Mar; 63(3):290-6. PubMed ID: 8677018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
    Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of direct application of estrogen aimed at lateral septum or dorsal raphe nucleus on lordosis behavior: regional and sexual differences in rats.
    Satou M; Yamanouchi K
    Neuroendocrinology; 1999 Jun; 69(6):446-52. PubMed ID: 10364697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
    Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
    Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A; Uphouse L
    Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of highly or relatively selective 5-HT1A receptor agonists on lordosis in female rats.
    Kishitake M; Yamanouchi K
    Zoolog Sci; 2003 Sep; 20(9):1133-8. PubMed ID: 14578574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
    Trevino A; Wolf A; Jackson A; Price T; Uphouse L
    Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT.
    Jackson A; Etgen AM
    Pharmacol Biochem Behav; 2001 Feb; 68(2):221-7. PubMed ID: 11267626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
    Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
    Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
    Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
    Jackson A; Uphouse L
    Brain Res; 1998 Jun; 796(1-2):299-302. PubMed ID: 9689482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lordosis in female hamsters and rats by 8-OH-DPAT treatment.
    Hebert TJ; Menard CS; Dohanich GP
    Physiol Behav; 1995 Mar; 57(3):523-7. PubMed ID: 7753891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist activation of 5-HT1A receptors in the median raphe nucleus and female rat lordosis behavior.
    Uphouse L; Maswood S; Caldarola-Pastuszka M
    Brain Res; 1994 Dec; 668(1-2):271-5. PubMed ID: 7704614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
    Uphouse L; Maswood S; Jackson A
    Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
    Uphouse L; Caldarola-Pastuszka M; Moore N
    Neuropharmacology; 1993 Jul; 32(7):641-51. PubMed ID: 8361579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
    Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Median and dorsal raphe injections of the 5-HT1A agonist, 8-OH-DPAT, and the GABAA agonist, muscimol, increase voluntary ethanol intake in Wistar rats.
    Tomkins DM; Sellers EM; Fletcher PJ
    Neuropharmacology; 1994; 33(3-4):349-58. PubMed ID: 7984273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive inhibition of lordosis by simultaneous treatments with GABA(A) and GABA(B) receptor agonists, muscimol and baclofen, in female rats.
    Wada S; Yamada S; Yamanouchi K
    Pharmacol Biochem Behav; 2008 Oct; 90(4):590-3. PubMed ID: 18539316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.